8-K filing — Curaleaf Holdings, Inc. (CURLF)
Filed: 2026-11-05 AccNo: 0001628280-26-070782 Size: 921 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Aurora Cannabis Shareholders Urged For No Action Against Curaleaf's Hostile Acquisition Offer
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Aurora Cannabis Q2 EPS $(0.32) Misses $(0.09) Estimate, Sales $86.021M Beat $72.167M Estimate
Aurora Cannabis Reports Q2 Revenue of CA$86.0 Million
Aurora Cannabis announced its second-quarter financial results, reporting revenue of CA$86.0 million, which exceeded analyst expectations.
Organigram Global to Acquire Aurora Cannabis in C$561M Deal
Organigram Global Inc. has entered into an arrangement agreement to acquire Aurora Cannabis Inc. for C$7.80 per share, valuing the company at approximately C$561 million.
Organigram To Acquire Aurora Cannabis For C$561 Million, Or C$7.80 Per Share
Canadian Investment Regulatory Organization Imposes Trading Halt on Aurora Cannabis Inc.
The Canadian Investment Regulatory Organization (CIRO) implemented a temporary trading halt on Aurora Cannabis Inc. (TSX: ACB) on November 3, 2026, pending the release of company news.